Verastem, Inc.
Datakwaliteit: 100%
VSTM
NASDAQ
Manufacturing
Chemicals
€ 5,31
▼
€ 0,28
(-5,01%)
Marktkapitalisatie: 494,07 M
Prijs
€ 5,63
Marktkapitalisatie
494,07 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue grew 96,99% annually over 5 years — strong growth
Negative free cash flow of -137,54 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 112,15%
Capital efficient — spends only 0,09% of revenue on capex
Groei
Revenue Growth (5Y)
96,99%
Boven sectorgemiddelde (1,92%)
Revenue (1Y)209,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-2040,63%
Onder sectorgemiddelde (-54,44%)
ROIC-102,19%
Net Margin-677,59%
Op. Margin-550,33%
Veiligheid
Debt / Equity
N/A
Current Ratio2,58
Interest Coverage-149,50
Waardering
PE (TTM|NTM)
-2,36 | -4,49
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,4 | -1,5 |
| P/B | — | 1,6 |
| ROE % | -2040,6 | -54,4 |
| Net Margin % | -677,6 | -41,5 |
| Rev Growth 5Y % | 97,0 | 1,9 |
| D/E | — | 0,3 |
Koersdoel Analisten
8 analisten
Buy
Huidig
€ 5,31
Koersdoel
€ 16,38
€ 14,00
€ 16,00
€ 19,00
Vooruitzicht
Forward K/W
-4,49
Forward WPA
-€ 1,18
Omzet Sch.
199,75 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 1,18
-€ 1,35 – -€ 0,90
|
199,75 M | 3 |
| FY2026 |
-€ 1,71
-€ 1,93 – -€ 1,55
|
117,27 M | 3 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,45
-€ 0,52 – -€ 0,41
|
26,58 M | 3 |
| 2026 Q1 |
-€ 0,47
-€ 0,50 – -€ 0,44
|
21,84 M | 3 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,50 | -€ 0,46 | +7,5% |
| Q32025 | -€ 0,61 | -€ 0,54 | +11,0% |
| Q22025 | -€ 0,75 | -€ 0,63 | +15,4% |
| Q12025 | -€ 0,78 | -€ 0,79 | -1,9% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 209,14% | Revenue Growth (3Y) | 245,08% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 96,99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 30,91 M | Net Income (TTM) | -209,47 M |
| ROE | -2040,63% | ROA | -112,28% |
| Gross Margin | N/A | Operating Margin | -550,33% |
| Net Margin | -677,59% | Free Cash Flow (TTM) | -137,54 M |
| ROIC | -102,19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,58 |
| Interest Coverage | -149,50 | Asset Turnover | 0,17 |
| Working Capital | 94,34 M | Tangible Book Value | -32,23 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,36 | Forward P/E | -4,49 |
| P/B Ratio | N/A | P/S Ratio | 15,98 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,47 | Fwd Earnings Yield | N/A |
| FCF Yield | -27,84% | ||
| Market Cap | 494,07 M | Enterprise Value | 397,09 M |
| Per Share | |||
| EPS (Diluted TTM) | -3,02 | Revenue / Share | 0,35 |
| FCF / Share | -1,57 | OCF / Share | -1,57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,09% | FCF Conversion | 65,66% |
| SBC-Adj. FCF | -148,30 M | Growth Momentum | 112,15 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 30,91 M | 10,00 M | 2,60 M | 2,60 M | 2,05 M |
| Net Income | -209,47 M | -130,64 M | -87,37 M | -73,81 M | -71,20 M |
| EPS (Diluted) | -3,02 | -3,66 | -3,93 | -0,38 | -0,41 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -170,13 M | -114,96 M | -92,08 M | -72,94 M | -61,41 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 114,60 M | 81,33 M | 61,36 M | 50,56 M | 39,35 M |
| SG&A Expenses | 81,15 M | 43,62 M | 30,73 M | 24,98 M | 24,12 M |
| D&A | — | — | — | — | — |
| Interest Expense | 1,14 M | 4,56 M | 4,14 M | 2,14 M | 9,97 M |
| Income Tax | 185.000,0 | 185.000,0 | — | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 246,44 M | 101,54 M | 149,72 M | 95,05 M | 108,66 M |
| Total Liabilities | 189,25 M | 130,43 M | 71,19 M | 47,66 M | 21,10 M |
| Shareholders' Equity | 57,20 M | -28,89 M | 57,37 M | 47,39 M | 87,56 M |
| Total Debt | 40,72 M | 40,72 M | 40,09 M | 24,53 M | — |
| Cash & Equivalents | 204,99 M | 88,82 M | 77,91 M | 74,93 M | 21,25 M |
| Current Assets | 223,41 M | 94,96 M | 143,68 M | 92,87 M | 105,74 M |
| Current Liabilities | 72,27 M | 30,97 M | 26,38 M | 21,66 M | 18,59 M |
{"event":"ticker_viewed","properties":{"ticker":"VSTM","listing_kind":"stock","pathname":"/stocks/vstm","exchange":"NASDAQ","country":"US"}}